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Abstract 
Background: As a metabolic engineering tool, an adaptive laboratory evolution (ALE) experiment was performed 
to increase the specific growth rate (µ) in an Escherichia coli strain lacking PTS, originally engineered to increase the 
availability of intracellular phosphoenolpyruvate and redirect to the aromatic biosynthesis pathway. As result, several 
evolved strains increased their growth fitness on glucose as the only carbon source. Two of these clones isolated at 
120 and 200 h during the experiment, increased their μ by 338 and 373 %, respectively, compared to the predecessor 
PB11 strain. The genome sequence and analysis of the genetic changes of these two strains (PB12 and PB13) allowed 
for the identification of a novel strategy to enhance carbon utilization to overcome the absence of the major glucose 
transport system.
Results: Genome sequencing data of evolved strains revealed the deletion of chromosomal region of 10,328 pb 
and two punctual non‑synonymous mutations in the dhaM and glpT genes, which occurred prior to their divergence 
during the early stages of the evolutionary process. Deleted genes related to increased fitness in the evolved strains 
are rppH, aas, lplT and galR. Furthermore, the loss of mutH, which was also lost during the deletion event, caused a 
200‑fold increase in the mutation rate.
Conclusions: During the ALE experiment, both PB12 and PB13 strains lost the galR and rppH genes, allowing the 
utilization of an alternative glucose transport system and allowed enhanced mRNA half‑life of many genes involved 
in the glycolytic pathway resulting in an increment in the μ of these derivatives. Finally, we demonstrated the deletion 
of the aas‑lplT operon, which codes for the main components of the phosphatidylethanolamine turnover metabolism 
increased the further fitness and glucose uptake in these evolved strains by stimulating the phospholipid degradation 
pathway. This is an alternative mechanism to its regeneration from 2‑acyl‑glycerophosphoethanolamine, whose utili‑
zation improved carbon metabolism likely by the elimination of a futile cycle under certain metabolic conditions. The 
origin and widespread occurrence of a mutated population during the ALE indicates a strong stress condition present 
in strains lacking PTS and the plasticity of this bacterium that allows it to overcome hostile conditions.
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Background
Adaptation based on mutations is essential to bacterial 
survival during environmental challenges, such as expo-
sure to antibiotics, variations in oxygen levels or tem-
perature, and during limited availability of carbon [1–4]. 
Bacterial adaptation that makes living cells extraordinar-
ily plastic is quick and evident within shorts periods of 
time [1–3], where often beneficial mutations occur that 
confer increased fitness in new conditions.
The adaptive capacity of bacteria can be exploited by 
metabolic engineering to enhance a particular character-
istic in a microorganism [1, 2, 5]. A short-term adaptive 
laboratory evolution (ALE) process has been performed 
in our group to increase the diminished growth capac-
ity of an E. coli strain (PB11) lacking the major glucose 
uptake system, phosphoenolpyruvate: carbohydrate 
phosphotransferase system (PTS). This PTS− strain 
shows a specific growth rate (μ) of 0.1 h−1 and was gen-
erated after ptsHIcrr operon inactivation in the JM101 
wild type parental strain that grows with a μ of 0.7  h−1 
on glucose as the only carbon source [6–8]. Despite the 
low growth capacity using glucose as the unique carbon 
source in the PB11 strain, this strategy diverts a large 
proportion of the phosphoenolpyruvate (PEP) to the 
aromatic biosynthesis pathway. However, because of its 
diminished growth rate, PB11 is not useful as an indus-
trial production strain. Therefore, an adaptive laboratory 
evolution (ALE) experiment was carried out with this 
strain by growing in a fermentor with glucose as the only 
carbon source fed at progressively higher rates (Fig. 1a). 
During this process, spontaneous mutants that grew 
faster on glucose were isolated. Further characterization 
of two strains obtained at 120 h (PB12) and 200 h (PB13) 
during the fermentation process showed increased μs of 
338 and 373  %, respectively, compared to the parental 
PB11 strain (Fig.  1a) [2, 6–8]. Because of this enhanced 
capacity, mainly the PB12 strain has been used for the 
overproduction of aromatic compounds with high yields 
[9–11].
These two evolved strains have been studied exten-
sively. Among their main characteristics are that glucose 
uptake is performed by the GalP permease and phospho-
rylated by the Glk glucokinase. Additionally, they have an 
increased glycolytic flux compared to the parental PB11 
strain and the co-utilization capacity of several carbon 
sources because of the absence of catabolic repression 
due to the lack of the PTS system, as previously described 
[6, 8, 12, 13]. In addition, whole genome sequence 
analyses of the PB12 strain allowed for the identification 
of 23 non-synonymous and 22 synonymous point muta-
tions, as well as a 10,328 bp chromosomal deletion. The 
effects of some of these genetic changes on the growth of 
the PB12 strain were also reported [2].
In the PB12 strain, was also deleted the aas-lplT operon 
during the ALE as part of the deletion of 10,328 bp chro-
mosomal region [2]. The products of this operon are 
involved in the 2-acyl-glycerophosphoethanolamine 
cycle (2-acyl-GPE). In wild type E. coli cells, the 2-acyl-
GPE cycle initiates with the transfer of the fatty acid 
moiety at the 1-position of phosphatidylethanolamine 
(PtdEtn) to the N-terminus of the major outer membrane 
lipoprotein (Lpp), resulting in 2-acyl-GPE formation 
(Fig. 2). Later, the 2-acyl-GPE is transported to the cyto-
solic side of the cell by the lysophospholipid transporter 
(LpIT) protein, coded by the lplT gene [14]. Once inside 
the cell, the bifunctional 2-acyl-GPE acyltransferase/
acyl-ACP synthetase (Aas), coded by the aas gene, re-
acylates the 2-acyl-GPE molecule using acyl-ACP as the 
acyl donor to regenerate PtdEtn. This is then exported by 
the lipopolysaccharide transporter MsbA (coded by the 
msbA gene) (Fig.  2). Because of the chromosomal dele-
tion in the PB12 strain, this cycle is not functional.
To determine if both the PB12 and PB13 evolved 
strains followed similar or independent adaptive paths 
and obtain a deeper insight into the genetic changes that 
these evolved strains developed to overcome the absence 
of the major glucose transport system, in this contribu-
tion whole genome sequencing of PB13 strain was car-
ried out. Additionally, RT-qPCR measurements of central 
carbon metabolism, phospholipid degradation genes 
and the evaluation of growth and metabolite concentra-
tion of key mutants were determined. Results indicate 
that an early loss of the chromosomal region of ~10  kb 
is also present in the PB13 strain. In addition, two genes 
with punctual non-synonymous mutations in dhaM and 
glpT are present in both PB12 and PB13 strains. It is pos-
sible that after the occurrence of these genetic changes, 
a divergence event took place between the two PTS 
derivative strains. Derived from these changes we pro-
pose a novel metabolic strategy to contend with carbon 
stress that takes advantage of the degradation PtdEtn 
pathway in these strains. We also describe and compare 
the genetic basis of growth adaptation of PB12 and PB13 
derivative E. coli variants, resulted from the same short 
term ALE process, that shows differential yields in the 
production of aromatic compounds, derived from spe-
cific genetic changes.
Keywords: Metabolic engineering, Metabolic plasticity, PTS system, Escherichia coli, Adaptive laboratory evolution, 
2‑Acyl‑glycerophosphoethanolamine cycle, Glycerol metabolism, Glucose metabolism
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Results and discussion
Detection and description of the genetic changes in the 
PB12 and PB13 strains
Comparative genome analysis of the PB13 strain   car-
ried out by Winter Genomics Inc., shows that similar to 
the PB12 strain genome, several point mutations that are 
present in the evolved PB12 and PB13 strains were gen-
erated during the ALE process compared to the PB11 
parental strain.
In the PB12 strain, 23 non-synonymous and 22 syn-
onymous point mutations were identified [2], while in 
the PB13 strain, 13 non-synonymous (Table  1) and 7 
synonymous point mutations were detected (Additional 
file  1: Table S1). Additionally, the same 10,328 nucleo-
tide deleted region from the chromosome in the PB12, 
was detected in the PB13 strain, removing the rppH, 
ygdT, mutH, ygdQ, ygdR, tas, lplT, aas, omrA, omrB, and 
part of ptsP and galR genes (Table 1). The analysis of the 
point mutations in non-coding regions (data not shown) 
and the synonymous point mutations that were detected 
in the PB12 strain [2] and in PB13 are not included in 
this work because the non-coding point mutations are 
located outside regulatory regions, and the synonymous 
mutations unlikely have any significant effect on the 
physiology of the strains (Additional file 1: Table S1).
Non‑synonymous point mutations in the evolved 
strains
From the 13 non-synonymous point mutations detected 
in the PB13 strain, 2 are located on genes with putative 
or unknown function, 9 on genes involved in metabolism 
or transport, and the last 2 mapped in genes involved 
in motility and its regulation (Table  1). One interesting 
mutation originated in the polA gene, which codes for 
DNA polymerase I that is involved in several DNA repair 
pathways [15–17]. This mutation resulted in a valine 
Fig. 1 Adaptive laboratory experiment. a Isolation of evolved strains from a continuous culture of the PB11 from Aguilar et al. [2]. The arrows 
indicate the isolation time for various strains including PB12 and PB13 strains. Dotted line indicates the end of the batch culture and the start of the 
continuous culture; numbers indicate dilution rates (D = h−1) as follows: 1 for D = 0.4, 2 for D = 0.6 and 3 for D = 0.8. b Chromosomal gene organi‑
zation in the parental wild type JM101 strain and in the laboratory evolved PB12 and PB13 strains. c PCR test for the chromosomal deletion in the 
evolved strains isolated at D = 0.4, 0.6 and 0.8, where the absence of the 10,328 bp chromosomal DNA fragment can be observed in 6 strains. Line 
1, (M) molecular weight marker; lines 2 and 3, amplification of the chromosomal region in the JM101 and PB11 strains controls respectively (12 kb); 
lines 4–9, amplification of the 1.9 kb from the chromosomal region in the six strains isolated during the continuous culture as follows: line 4 and 5, 
PB12 and the second strain isolated at D = 0.4, line 6 and 7, first and second strains isolated at D = 0.6, line 8 and 9, first strain isolated at D = 0.8 and 
PB13 strain; line 10, (M) molecular weight marker
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instead of an alanine codon at position 695 of the pro-
tein inside of the Klenow fragment, which is involved in 
proofreading activity (Table 1). This mutation is located 
in a non-conserved region [18, 19]; however, this poly-
merase changes its conformational state according to its 
different roles, implicating several amino acids [20, 21]. 
In that sense, it is possible that this modification could 
have an effect on the polymerase proofreading activity.
Two relevant mutations are located in the dhaM and glpT 
genes and were detected in both evolved strains. The dhaM 
gene codes for the DhaM protein, which is a component of 
the dihydroxyacetone kinase (DhaK). This component con-
sists of three PTS homologous domains (EI, Hpr and the 
A domain of the EII protein) [22]. The mutation generates 
an opal stop codon (TGA) instead of a tryptophan codon 
(TGG) at position 346 of the protein (Table 1), which results 
in a truncated protein in the EI homologous domain.
The other shared punctual mutation was on the glpT 
gene, which is co-transcribed with the glpQ gene. The glyc-
erophosphoryl diester phosphodiesterase (GlpQ) protein 
Fig. 2 The 2‑acyl‑GPE cycle. The 2‑acyl‑GPE cycle initiates at the periplasmic side of the inner membrane with the conversion of PtdEtn into 2‑acyl‑
GPE by the apolipoprotein N‑acyltransferase Lnt which transfers the fatty acid moiety from the sn‑1 position of phosphatidylethanolamine (PtdEtn) 
to the N terminus of the major outer membrane lipoprotein (Lpp). The 2‑acyl‑GPE is then transported to the cytoplasm through LplT protein. Once 
inside, the PtdEtn molecule is regenerated by the action of the 2‑acyl‑GPE acyltransferase/acyl‑ACP synthethase Aas protein by the re‑acylation 
of the 2‑acyl‑GPE molecule. Then the PtdEtn molecule is exported through the MsbA protein to the periplasmic side of the inner membrane. The 
abbreviations are as follows: phosphatidylethanolamine (PtdEtn), 2‑acyl‑glycerophosphatidylethanolamine (2‑acyl‑GPE), fatty acid (FA), Lipoprotein 
(Lpp), acylated lipoprotein (Acyl‑Lpp), Apolipoprotein N‑acyltransferase (Lnt), phospholipase A type 2 (PLA2), lipopolysaccharide transporter (MsbA), 
lysophospholipid transporter (LplT), 1‑acylglycerol‑3‑phosphate O‑acyltransferase (PlsC), 2‑acylglycerophosphoethanolamine acyltransferase/acyl‑
ACP synthetase (Aas), acyl‑ACP synthetase activity (ACP), 2‑acylglycerophosphoethanolamine acyltransferase activity (ACS), Adenosine triphosphate 
(ATP), Adenosine monophosphate (AMP), inorganic pyrophosphate (PPi)
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encodes a periplasmic glycerophosphoryl diester phospho-
diesterase activity (GDP), which hydrolyzes deacylated phos-
pholipids (glycerophosphoalcohol from phospholipids) to an 
alcohol and glycerol-3-P (G3P) that is subsequently trans-
ported into the cell by the glycerol-3-phosphate:phosphate 
antiporter (GlpT) transporter (Fig. 3) [23]. GlpT is the major 
G3P uptake system in E. coli [24]; this protein consists of 12 
transmembrane α-helices, seven cytoplasmic, and six peri-
plasmic regions [25]. The mutation is located in a conserved 
region on the fourth transmembrane α-helix, generating a 
leucine instead of a proline codon (Table  1). Interestingly, 
even though the ALE was carried out on glucose as the 
only carbon source, two point mutations appeared on genes 
involved in the glycerol metabolism pathway in both PTS− 
strains, suggesting a possible role for these two proteins dur-
ing growth recovery on glucose.
In the PB13 strain, the appearance of a point muta-
tion was noted in the msbA gene, which codes for the 
Table 1 Mutations that occurred in the evolved PB13 strain during the ALE process
A: presents the 13 non-synonymous point mutations in structural genes that changed the code for a different amino acid when compared to the parental PB11 and 
JM101 strains genomes. In addition 8 synonymous point mutations in different genes were also detected (Additional file 1: Table S1). The non-synonymous point 
mutations dhaM and glpT shared by PB12 [4] and PB13 strains are in italic letters. B: presents lost genes in the chromosomal region deleted. Basic descriptions of these 
genes were taken from http://www.ecocyc.org. WG Winter Genomics Inc.
Gene Basic description Mutations
JM101 PB13 Nucleot. Pos/Chan
(A) JM101 vs PB13 Non‑synonymous point mutations (WG)
Hypothetical/putative/unknown function genes
 wzyE Predicted Wzy protein involved in ECA polysaccharide chain elongation GCG GtG 221 74 A‑V
 ydiM Predicted transporter of the major facilitator superfamily (MFS) of transporters TTC cTC 982 328 F‑L
 ydaF Predicted protein ACT AaT 116 39 T‑N
Metabolism and transport
 bglA One of several 6‑phospho‑β‑glucosidases in E. coli CCG CtG 839 280 P‑L
 deoB Phosphodeoxyribomutase; catabolic enzyme of the pyrimidine deoxyribonucleosides degradation 
pathway
GAC GgC 848 283 D‑G
 dhaM Dihydroxyacetone kinase subunit M, homologous to certain PTS components TGg TGa 1038 346 W-stop
 glpT Major uptake transporter for glycerol-3-phosphate, belongs to the major Facilitator Superfamily (MFS) CCG CtG 416 139 P-L
 ispG IspG, catalyzes the sixth step in the methylerythritol phosphate pathway GTC GcC 749 250 V‑A
 mepA Penicillin‑insensitive d‑alanyl‑d‑alanine (DD) endopeptidase CGT CaT 197 66 R‑H
 msbA ATP‑binding lipopolysacchride transport complex ACG gCG 367 123 T‑A
 xapB Xanthosine MFS transporter ACC gCC 1051 351 T‑A
 ydcT YdcT is an ATP‑binding component of a predicted spermidine/putrescine ABC transporter CCG CtG 113 38 P‑L
Cellular constituents
 fliN FliN, is one of three components of the flagellar motor’s “switch complex” GAT GgT 371 124 D‑G
Regulatory genes
 polA DNA Polymerase I (Pol I) GCG GtG 2084 695 A‑V
(B) JM101 vs PB13 Deletions (WG)
 ptsP Member of a second PTS chain involved in nitrogen metabolism Pres Abs – –
 rppH RNA pyrophosphohydrolase that initiates mRNA degradation by hydrolysis of the 5′-triphosphate end Pres Abs – –
 ygdT Hypothetical protein Pres Abs – –
 mutH dGATC endonuclease in the MutHLS complex, the methyl-directed mismatch repair pathway Pres Abs – –
 ygdQ Putative transport protein Pres Abs – –
 ygdR Predicted protein Pres Abs – –
 tas Putative NAD(P)‑linked reductase that acts in starvation‑associated mutations Pres Abs – –
 lplT Lysophospholipid transporter (LplT) Pres Abs – –
 aas 2‑acylglycerophosphoethanolamine acyltransferase/acyl‑ACP synthetase Pres Abs – –
 omrA Small RNA that is involved in regulating the protein composition of the outer membrane Pres Abs – –
 omrB Small RNA that is involved in regulating the protein composition of the outer membrane Pres Abs – –
 galR DNA-binding transcription factor; represses transcription of the operons involved in transport  
and catabolism of D-galactose
Pres Abs – –
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lipopolysaccharide transporter MsbA. This protein is 
involved in the translocation of PtdEtn to the periplasmic 
side of the inner membrane once this molecule has been 
recycled from 2-acyl-GPE by the Aas protein during the 
2-acyl-GPE cycle in the cytoplasm [14] (Fig. 2). The muta-
tion is located at position 123 of the protein in the trans-
membrane domain [26] and resulted in the substitution of 
a threonine by an alanine residue. Depletion or loss of func-
tion of MsbA results in the accumulation of lipopolysac-
charide and phospholipids in the inner membrane of E. coli 
[27]. The relevance of this particular mutation on the physi-
ology of this strain is in principle of low impact in the turno-
ver of PtdEtn because the genes encoding two proteins (Aas 
and LplT) involved in the 2-acyl-GPE cycle were lost dur-
ing the ALE process. However, its occurrence, together with 
the aas-lplT operon deletion (discussed later) suggests that 
the adaptation in the PB12 and PB13 strains was directed 
towards the loss of function of the 2-acyl-GPE cycle.
According with their functions is unlikely that the 
remaining genes in PB13 with non-synonymous point 
mutations have an impact on fitness (Table 1).
Chromosomal deletion during the short term ALE 
process
As mentioned and reported for the PB12 strain [2], the dele-
tion of a 10,328 bp chromosomal fragment including 12 con-
tiguous genes (rppH, ygdT, mutH, ygdQ, ygdR, tas, lplT, aas, 
omrA, omrB, ptsP and galR) was detected in both PB12 and 
PB13 evolved strains. The deletion limits mapped within the 
ptsP and galR genes, resulting in a fusion of the remaining 
segments of these two genes (Fig. 1b). Earlier work describ-
ing the effect on several central metabolic gene transcripts 
and its impact on the glycolytic pathway allowing for bet-
ter glucose uptake due to the absence of the rppH gene has 
been published [2]. The detection of the same missing region 
in the PB13 chromosome establishes the importance of the 
adaptive nature of this DNA fragment deletion and proves 
that both strains were derived from the same ancestor.
Evolutionary divergence between the PB12 
and PB13 strains
During the ALE experiment, strain PB11 was grown in a 
batch culture fermentor containing M9 minimal medium 
supplemented with 2 g/L of glucose (Fig. 1a). Under these 
conditions, a selection pressure was generated, favoring 
mutants that acquired the capacity to grow faster than 
the original PB11 parental strain. The batch culture was 
maintained until the stationary phase before starting 
a continuous culture, in which fresh medium was fed 
at progressively higher dilution rates (Fig.  1a) [2, 6, 7]. 
This procedure allowed for the isolation of the mutants 
generated during the batch culture according to their 
growth rates. Because two strains were isolated at dif-
ferent dilution rates during the continuous culture (0.4, 
0.6 and 0.8 h−1), we tested for chromosomal integrity in 
six strains, including PB12 and PB13. All clone variants 
Fig. 3 Phosphatidylethanolamine (PtdEtn) degradation pathway in E. coli. a The degradation pathway initiates with the conversion of PtdEtn into 
2‑acyl‑GPE by the apolipoprotein N‑acyltransferase Lnt as shown in Fig. 2, or by the outer membrane phospholipase A PldA. b After the 2‑acyl‑GPE 
formation, in the periplasm, the lysophospholipase L2 PldB, hydrolyzes the bond to the remaining acyl group of the lysophospholipid, generat‑
ing a fatty acid and glycerophosphodiester molecules. c Later, the glycerophosphoryl diester phosphodiesterase GlpQ enzyme, hydrolyzes the 
glycerophosphodiesters molecules into G3P and ethanolamine. The products of the degradation, G3P and FA are internalized by the cell through 
the GlpT and FadD transporters and can be further metabolized through the glycolytic and β‑oxidation pathway, respectively. E. coli can also use 
ethanolamine as source of carbon and nitrogen [37]; however, a transporter is not described yet. The abbreviations are as follows: phosphatidyletha‑
nolamine (PtdEtn), 2‑acyl‑glycerophosphatidilethanolamine (2‑acyl‑GPE), fatty acid (FA), Glycerol‑3‑phosphate (G3P), glycerophosphodiester (GPD), 
Lipoprotein (Lpp), acylated lipoprotein (Acyl‑Lpp), apolipoprotein N‑acyltransferase (Lnt), phospholipase A type 2 (PLA2), lysophospholipase L2 
(PldB), glycerophosphoryl diester phosphodiesterase (GlpQ), fatty acyl‑CoA synthetase (FadD), glycerol‑3‑phosphate:phosphate antiporter (GlpT)
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lacked the same chromosomal fragment (Fig. 1c), indicat-
ing that all strains were derived from the same ancestor. 
This strongly suggests that the chromosomal deletion 
is an important early adaptive event in the evolutionary 
process of this PB11 strain. Interestingly, this same dele-
tion was detected in other evolved strains derived from 
a duplicate of the ALE experiment using the same PB11 
strain (data not shown).
Once the derivatives acquired a growth advantage due 
to the loss of this specific chromosomal fragment, the 
cells were able to increase their μ and continued to accu-
mulate mutations with an increased capacity due to the 
absence of the mutH gene that was also lost in the dele-
tion. Although the precise emergence of dhaM and glpT 
point mutations is unknown, it is probable that these 
mutations were generated after the chromosomal dele-
tion event because the cell has to overcome the absence 
of its principal phospholipid turnover mechanism, and 
these mutations could have a significant role to contend 
with this lost capacity, as discussed later (Figs.  2, 3). In 
addition, we tested for the presence of dhaM and glpT 
mutations in all the other intermediate strains and found 
both in all of them (data not shown). The shared muta-
tions in the PB12 and PB13 strains establish that the 
divergence between PB12 and PB13 took place after the 
chromosomal deletion and the appearance of the dhaM 
and glpT point mutation events, likely at early stages of 
the exponential growth phase.
With the enormous stress that the absence of the 
major glucose transport system represents, a muta-
genic response was triggered in the population, which 
in turn resulted in better adaptation capacities [1, 2, 28]. 
Therefore, during this ALE process, the deletion of this 
important chromosomal fragment was originated in the 
parental PB11 strain. This event implied the appearance 
of a population with a higher mutation rate than the 
wild type due to the absence of the mutH gene, which 
was located in the missing chromosomal region and 
is involved in DNA repair pathways [29]. The mutation 
rate in both evolved strains was measured based on the 
mutation rate in the rpsL locus (streptomycin-resistant 
mutants). Mutation rates were determined by a modified 
Luria-Delbrück fluctuation test, employing the Ma-San-
dri-Sarkar maximum likelihood method (MSS-MLE) and 
the Lea-Coulson method of the median (LC) in the esti-
mation of the number of mutants [30–32]. As expected, 
increased mutation rates were observed in the evolved 
strains due to the deletion of mutH. However, a 5-fold 
higher mutation rate was detected in the PB13 strain 
compared to the PB12 strain (Fig.  4; Additional file  2: 
Table S2). A PB11ΔReg derivative (which lacks the entire 
chromosomal fragment deleted in the evolved strains) 
showed a similar mutation rate to that of the PB12 strain, 
so it is feasible to propose that the PB13 strain carries at 
least one additional mutation that increases its mutation 
rate. Interestingly, the point mutations detected in the 
PB12 strain were higher than the observed in the PB13 
despite having a lower mutation rate. Since all five pre-
viously isolated evolved strains did not carry the polA 
mutation (data not shown), a possible explanation is that 
the polA mutation, has arisen during the last stages of the 
evolutionary process, and is responsible for the higher 
mutation rate in the PB13 strain.
Contribution of the absent chromosomal fragment 
on growth rate
It has been reported that in strain PB12, the absence of 
the rppH and galR genes are important for growth rate 
increases on glucose [2]. To establish the contribution of 
additional genes within the deleted chromosomal frag-
ment on the growth rate of the evolved strains (Fig. 5b), 
four different PB11 derived strains were constructed 
(Fig. 5a). In these derivative strains, rppH (as previously 
reported for PB12 strain [2]), aas-lplT, or the entire chro-
mosomal fragment were eliminated. The selection of 
these genes was made after considering their functions 
and its possible effect on growth (mRNA lifetime for 
the rppH gene as previously reported, as well as PtdEtn 
turnover for the aas-lplT operon). A 154  % growth 
increase was observed in the PB11Δaas-lplT strain, 
while 261 % and 285 % growth increases were observed 
in the PB11ΔrppH and PB11Δaas-lplT-rppH double 
mutant derivatives, respectively, where an epistatic effect 
was evident (Fig. 5a). Finally, the PB11ΔReg had a simi-
lar μ compared to the PB11 double mutant (0.38 h−1 vs 
0.37 h−1, respectively), confirming the epistasis observed 
previously (Fig.  5a). With these results, it is possible 
to establish that the absence of the rppH gene, the aas-
lplT operon, and the galR gene are primarily responsi-
ble for the increased μ on glucose in the evolved strains. 
Other important data from these results imply that the 
point mutations in the PB12 and PB13 strains have only 
a minor impact on growth recovery (Fig. 5a). Therefore, 
the growth increase due to the loss of the chromosomal 
fragment contributes approximately 86  % in PB12 and 
79  % in PB13, while the point mutations in PB12 and 
PB13 contribute only 14 % and 21 %, respectively.
Importance of the mutated glpT and dhaM genes 
in the evolved strains
As was mentioned (Table 1), the two evolved strains share 
two point mutations in two different genes, suggesting an 
adaptive role To understand the physiological importance 
of these genes during the growth on glucose (see Figs. 2, 
3), a complete set of single mutants in all strains was con-
structed. As seen in Table 2, the complete inactivation of 
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Fig. 4 Mutation rates test. Mutation rates in the laboratory evolved strains and its parentals were determined by a modified Luria‑Delbrück fluctua‑
tion test, employing the MSS‑MLE and the LC methods  in the estimation of the number of mutants. The mutation rate is higher in the PB12 and 
PB13 strains as compared to JM101 and PB11 strains. Mutation frequency was also calculated (Freq). All the results have a confidence interval of 
95 %. A detailed table is available in the Additional file 2: Table S2
Fig. 5 Contribution of the deletion of the chromosomal fragment on growth rate in derivatives of the PB11 strain. a The specific growth rates (μ) 
on glucose as the only carbon source of different PB11 derived strains were determined in order to establish the contribution of some absent genes 
over the growth in a PTS− strain. b The gene order inside the chromosomal fragment is shown
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the glpT gene decreased the μ in both evolved strains. A 
growth reduction of 43 and 47 % was observed in PB12 
and PB13, respectively. Interestingly there was no growth 
reduction in the PB11 or JM101 strains.
We also evaluated the glpQ gene, which is co-tran-
scribed with glpT and is involved in the same phospho-
lipid degradation pathway (Figs. 2, 3). Very similar results 
to those observed with the elimination of glpT occurred. 
Elimination of the glpQ gene did not affect the growth 
of the parental JM101 and PB11 strains, but a 40 and 
45 % of growth reduction was observed in the PB12 and 
PB13 evolved strains, respectively (Table 2). These results 
strongly suggest the participation of this pathway in the 
growth recovery of the evolved strains. In agreement 
with this, both evolved strains lack the aas-lplT operon 
that is involved in membrane phospholipid recycling, 
which supports this last hypothesis.
To evaluate the contribution of the second shared 
punctual non-synonymous mutation on the physiology 
of the PTS− strains, individual ΔdhaM mutants were 
generated in all strains (Table  2). The results showed a 
decrease in the μ of all the PTS− mutant strains, espe-
cially in the evolved ones. The strain PB11 had a slight 
decrease in its μ, which is not considered significant. 
However, the PB12 and the PB13 strains had decreases 
of 16 and 40  %, respectively (Table  2). These results 
suggest that the DhaK could play an important role in 
the growth of the evolved strains, particularly in the 
PB13 strain. Interestingly, this protein (similar to the 
GlpT transporter) is involved in the glycerol pathway, 
which suggests that the phospholipid-glycerol-3-P deg-
radation pathway contributes to the fitness increase in 
both evolved strains (Fig.  3). Nevertheless, it is unclear 
how this mutation provides an advantage because this 
mutation should decrease the phosphorylation capaci-
ties of the protein, which in turn would reduce the con-
version of dihydroxyacetone (DHA) to dihydroxyacetone 
phosphate (DHAP) that serves as an intermediary in 
the glycolytic pathway. Another important point is that 
under glycolytic conditions, wild type cells are not able 
to produce DHA because this compound is generated 
from glycerol and not from glucose. It is possible that the 
consumption of G3P from the phospholipid metabolism 
in the evolved strains could be related to this behavior, 
but we are unable to completely explain the possible 
effect on cell physiology.
Advantage and contribution of the absence of the 
aas‑lplT operon on the growth rate of the evolved 
strains
The phospholipids in the membrane of E. coli are phos-
phatidylethanolamine (PtdEtn) (75–80 %), phosphatidyl-
glycerol (PtdGro) (15–20 %), and cardiolipin (CL) (~6 %) 
[33, 34]. PtdEtn can be metabolized by two pathways. The 
first route involves the recycling of this molecule by the 
2-acyl-GPE cycle, in which all of its principal constituents 
are involved in a cycle and are not degraded further. The 
second metabolic pathway involves the complete degra-
dation of the phospholipid molecule to G3P, fatty acids, 
and ethanolamine (Figs. 2, 3) and that could function in 
both evolved strains.
This second pathway in wild type cells requires the 
sequential activity of the apolipoprotein N-acyltrans-
ferase Lnt or the phospholipase PldA to generate a 
2-acyl-GPE (Fig. 3a) and the inner membrane phospho-
lipase PldB to generate a glycerophosphodiester and free 
fatty acid molecules from 2-acyl-GPE (Fig. 3b). Later in 
this pathway, the GDP protein coded by the glpQ gene 
hydrolyzes glycerophosphodiester to generate ethan-
olamine and G3P (Fig. 3c). The G3P molecule is in turn 
internalized from the periplasmic space to the cytoplasm 
through the GlpT transporter that is coded by the glpT 
gene [35]. The free fatty acids formed during PldB action 
are converted to CoA derivatives by the activity of fatty 
acyl-CoA synthetase (FadD) [36]. The G3P molecule is 
then redirected by the cell towards glycolysis or the de 
novo phospholipid biosynthesis pathway. The wild type 
cell could send fatty acids towards β-oxidation or to the 
phospholipid synthesis pathway (Fig. 3c). E. coli can also 
Table 2 Specific growth rates of  the JM101, PTS− strains 
and their derivatives with important inactivated genes
Strain μ (h−1) %
JM101 0.71 100
 JM101ΔglpT 0.74 104
 JM101ΔdhaM 0.71 100
 JM101ΔglpQ 0.72 101
 JM101ΔfadD
PB11 0.13 100
 PB11ΔglpT 0.13 100
 PB11ΔdhaM 0.11 85
 PB11ΔglpQ 0.13 100
 PB11ΔfadD 0.12 92
 PB11Δaas‑lplT‑fadD 0.12 92
PB12 0.44 100
 PB12ΔglpT 0.25 57
 PB12ΔdhaM 0.37 84
 PB12ΔglpQ 0.26 60
 PB12ΔfadD 0.32 73
PB13 0.47 100
 PB13ΔglpT 0.25 53
 PB13ΔdhaM 0.28 60
 PB13ΔglpQ 0.26 55
 PB13ΔfadD 0.29 62
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use ethanolamine as source of carbon and nitrogen [37]; 
however, a transporter has not been described.
It was previously reported that E. coli mutants with 
completely inactivated lplT and aas genes have a dimin-
ished PtdEtn turnover, resulting in an increase of peri-
plasmic 2-acyl-GPE that is approximately 1/3 higher in 
the ΔlplT mutants compared to the wild type strain. The 
accumulation of 2-acyl-GPE is higher in the Δaas ΔpldB 
double mutants [14], which suggests a central role for 
the proteins with lysophospholipase A2 activity (PldB) 
on the alleviation of the 2-acyl-GPE accumulation by the 
secondary degradation route. It has also been reported 
that Δaas mutants have an altered membrane phospho-
lipid composition and accumulate both 2-acyl-GPE and 
acyl-phosphatidylglycerol (acyl-PtdGro) [38]. The acyl-
PtdGro molecule is the result of the addition of a fatty 
acid from 2-acyl-GPE to the molecule of PtdGro by the 
lysophospholipase A2 PldB protein, establishing an addi-
tional fate for the 2-acyl-GPE that is modified to glyc-
erol-3-phosphoethanolamine (a substrate for the GDP 
enzyme) (Figs. 2, 3).
With these elements, it is likely that 2-acyl-GPE and/or 
acyl-PtdGro derived from PtdEtn could be accumulated 
in the periplasmic space in the PB12 and PB13 evolved 
strains compared to the wild type parental JM101 due 
to the absence of their recycling machinery (Aas and 
LplT). Therefore, to understand the lipid metabolism in 
the PB12 and PB13 strains, lipids were analyzed by thin-
layer chromatography (TLC). The results showed no 
significant differences between all the strains (data not 
shown) suggesting the use of an alternative pathway in 
the evolved strains, thus preventing the accumulation of 
lyso-phospholipids species, and an important metabolic 
plasticity in these strains.
The relative amounts of free fatty acids in E. coli reflect 
a steady state situation defined by formation and con-
sumption of free fatty acids in a given physiological con-
dition. In FadD-deficient mutants, consumption of free 
fatty acids is eliminated [39] and therefore a more precise 
estimate of free fatty acid formation can be obtained. To 
test the utilization of the phospholipid degradation path-
way in the PB12 and PB13 evolved strains, the fadD gene 
was inactivated in the different genetic backgrounds. The 
FadD protein catalyzes the esterification of fatty acids into 
metabolically active CoA thioesters concomitant with 
their transport [36], which in this condition are derived 
from phospholipid degradation (Figs.  6, 7). Inactivation 
of fadD in the PB12 and PB13 evolved strains decreased 
the μ in these derivatives (Table 2), indicating an impor-
tant role of this protein in the evolved strains. Therefore, 
the content of free fatty acids was determined in all the 
derivative strains. Surprisingly, the JM101ΔfadD and the 
PB11ΔfadD strain increased the relative amount of free 
fatty acids up to 12 and 18 %, respectively after 72 h, sug-
gesting that the degradation pathway is also active in both 
JM101 and PB11 strains. However, this characteristic does 
not represent an advantage for the growth of these strains 
because JM101 is not limited by carbon consumption and 
in the PB11 the 2-acyl-GPE cycle is present. However, a 
33 % increase in the free fatty acid concentration after 72 h 
in the PB13ΔfadD was observed (Fig.  6), confirming the 
utilization of this degradation pathway in PB13 and sug-
gesting that the lack of the major membrane phospholipid 
turnover cycle allowed for more efficient carbon metabo-
lism in this strain. The decrease in the growth rate of the 
ΔfadD and the ΔglpT mutant strains (Table  2) indicates 
that this accumulation is due to the PtdEtn degradation 
pathway. This strategy results in a concomitant optimiza-
tion of the carbon sources, probably through the elimina-
tion of this turnover cycle, which in the PTS− scenario 
results in a new metabolic capacity to assimilate PtdEtn. 
This last proposition is supported by the increase in μ in 
the PB11 strain when the aas-lplT operon is inactivated 
(Fig. 5a). In the PB12ΔfadD strain, the FA accumulation 
was approximately 8 % after 72 h (Fig. 6) and the growth 
decreased by 27  % (Table  2), suggesting that the growth 
reduction in this strain is due to a different mechanism 
that could block the pathway rather than a reduction in 
the re-assimilation products from phospholipid degrada-
tion. Therefore, it is feasible that the regulation for this 
pathway in the PB12 strain works in a slightly different 
manner. In that sense, non-synonymous point mutations 
in yjjU and rssA (which code for predicted esterases) are 
present in the PB12 strain [2]. Functional and mutational 
predictions on the proteins coded by these genes in order 
to evaluate its contribution in the fatty acid accumulation 
behavior of this strain were carried out (data not shown), 
however the results are not conclusive.
RT‑qPCR mRNA expression values of central carbon 
metabolism, PtdEtn degradation, β‑oxidation 
and phospholipid biosynthesis genes in the 
evolved strains
RT-qPCR analysis of the main central carbon metabolism 
genes in the PB13 strain was performed. The expression 
levels of the same genes in the PB11 and PB12 strains 
were published in previous studies [2, 6, 7]. Interest-
ingly, both evolved strains had similar expression values 
in most of the genes involved in the metabolic pathways 
tested (Additional file 3: Figure S1; Additional file 4: Table 
S3). This indicates that during the early stages of the evo-
lutionary process (minimum 120  h), the main genetic 
changes responsible for the rearrangement of the expres-
sion profile were fixed; among these are the chromo-
somal fragment deletion and the two non-synonymous 
point mutations in the glpT and dhaM genes.
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Increased global concentrations of mRNAs were 
detected due to the absence of rppH in PB11ΔrppH, 
PB12 and PB13 strains [2, 6, 7]. However, these higher 
mRNA concentrations were less intense in both evolved 
strains (Additional file  3: Figure S1; Additional file  4: 
Table S3), which suggests that one or more mutations 
are contributing to these phenomena. Despite the simi-
larities, the higher transcription values of the gene cod-
ing for the galactose permease (galP) in the PB13 strain 
should be noted because its value increased 38-fold, 
while the PB12 increase was approximately 13-fold com-
pare to the parental JM101 strain. Considering the higher 
growth rate in the PB13 strain (approximately 10 % com-
pared to PB12), it is likely that the increased transcription 
of the galP gene provides an increased glucose uptake in 
this strain [6].
Supporting the proposition, as result of the activa-
tion of the degradation pathway of PtdEtn in the evolved 
strains, the expression values of the genes involved the 
degradation of this molecule are increased in the evolved 
strains, indicating the use of the PtdEtn degradation 
pathway as a metabolic alternative to contend with the 
accumulation of lysophospholipid species. On the other 
hand, most of the values of the PB11 strain were similar 
to those of the control parental JM101 strain (Table  3). 
Despite the expected expression profile, there are two 
interesting aspects to mention. One is regarding the first 
step in the deacylation of the PtdEtn molecule, which 
during the 2-acyl-GPE cycle is carried out by the Lnt pro-
tein (Fig. 2). The transcripts of the lnt gene are increased 
2.5-fold only in the PB13 strain. Apparently, during the 
degradation pathway in the evolved strains, this initial 
step could be performed mainly by the phospholipase 
A PldA, coded by the pldA gene, which expression val-
ues are increased about 3 and 5-fold in the PB12 and 
PB13 strains, respectively (Table  3). A second remark-
able aspect is observed in the expression values of the 
glpT gene, which is the only gene involved in the PtdEtn 
degradation pathway that increased their mRNA level 
(2.6-fold) in the PB11 strain. On the other hand, the 
expression values of this gene for the evolved strains are 
increased 2.2 and 63.5-fold in the PB12 and PB13 strains, 
respectively (Table 3), which suggests a high relevance in 
the reassimilation of G3P for an enhanced metabolism. 
Fig. 6 Accumulation of free fatty acids in different E. coli strains. In vivo labeling of E. coli using [14C]acetate and after thin‑layer chromatographic 
separation of lipids was performed. The accumulation of free fatty acids of the different ΔfadD E. coli JM101, PB11, PB12 and PB13 derivative strains 
at 24, 48 and 72 h of growth were determined. The experiments were made by triplicate. In all strains lacking the fadD gene, a progressive increase 
of free fatty acid was observed over time due to a lack of consumption. The PB11ΔfadD and PB13ΔfadD strains reached 18 and 33 % of the total 
lipidic species after 72 h. Interestingly, the PB12ΔfadD reached around 8 % of free fatty acids while the JM101ΔfadD reached about 12 % in 72 h of 
growth. The control strains are capable to consume completely the generated free fatty acids during the growth
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The unusual overexpression in the PB13 strain for the 
glpT and other genes (as galP) reflects the differential 
regulatory rearrangement in this strain as result of one or 
the combined effect of more than one genetic change.
Regarding the expression of genes involved in 
β-oxidation, high transcripts values were observed in all 
the strains, especially for the PB11 strain. This strain pre-
sents a permanent stress condition due to its inability for 
glucose uptake. As a result, carbon scavenging responses 
are triggered that allow the induction of several catabolic 
pathways [6–8]. As was presented in this contribution 
(Fig.  6), the PB11 strain accumulated significant levels 
of free fatty acids, even higher than those observed for 
PB12, suggesting that this scavenging strategy favors the 
free fatty acids reassimilation and further degradation in 
PB11 strain in order to increases the survival chances. 
It is important to mention that the inactivation of the 
aas-lplT operon in the PB11 strain allows a significant 
μ increase, which indicates that both, the 2-acyl-GPE 
cycle and the PtdEtn degradation pathways co-exist in 
this strain. In consequence, after the operon deletion, the 
2-acyl-GPE cycle is no longer functional and all the car-
bon flow is directed through the degradation pathway to 
be reused as carbon molecules.
The high expression values observed for most of the 
genes coding for the free fatty acid degradation pathway 
in the evolved strains (Table 3), indicates as proposed, the 
reuse of free fatty acid molecules from the PtdEtn degra-
dation pathway, which enhances their metabolism.
The expression values of the genes involved in the 
fatty acids biosynthetic pathway were also measured. 
The results show a diminished expression of most of 
these genes in the PB11 strain. On the other hand, both 
evolved strains present, high expression values (Table 3). 
Fig. 7 Metabolic strategy in evolved strains lacking the aas‑lplT operon. Proposed phosphatidylethanolamine (PtdEtn) metabolism model in PB12 
and PB13 strains where the deletion of aas‑lplT operon is responsible of the lack of the 2‑acyl‑GPE cycle that in turn was apparently replaced with 
the utilization of the degradation pathway. In these evolved strains two additional mutations were detected: in the glpT and dhaM genes. At least 
the glpT mutation could be playing a role in these strains for PtdEtn utilization and faster growth on glucose. The abbreviations are as follows: phos‑
phatidylethanolamine (PtdEtn), 2‑acyl‑glycerophosphatidylethanolamine (2‑acyl‑GPE), fatty acid (FA), Lipoprotein (Lpp), acylated lipoprotein (Acyl‑
Lpp), Apolipoprotein N‑acyltransferase (Lnt), phospholipase A type 2 (PLA2), phosphatidylethanolamine transporter in the 2‑acyl‑GPE cycle (MsbA), 
lysophospholipid transporter (LplT), 1‑acylglycerol‑3‑phosphate O‑acyltransferase (PlsC), 2‑acylglycerophosphoethanolamine acyltransferase/
acyl‑ACP synthetase (Aas), acyl‑ACP synthetase activity (ACP), 2‑acylglycerophosphoethanolamine acyltransferase activity (ACS), glycerophosphoryl 
diester phosphodiesterase (GlpQ), fatty acyl‑CoA synthetase (FadD), glycerol‑3‑phosphate:phosphate antiporter (GlpT)
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These data, are in agreement with the proposal, since 
the absence of the 2-acyl-GPE cycle in the evolved 
strains, force the cells to replenish the fatty acids needed 
by restoring through this pathway the phospholipids 
required for a suitable performance. In this regard, it 
is possible to suggest that the utilization of both path-
ways in the PB11 results in a waste of carbon molecules, 
despite the further restoration of phospholipid mol-
ecules. Then, the loss of the 2-acyl-GPE cycle and the 
other mutations that allowed the degradation of PtdEtn 
in PB12 and the PB13 strains increased the fitness and 
the growth rate in these evolved derivatives.
Metabolic strategy in evolved strains lacking the 
ptsHIcrr, aas‑lplT and galR genes
It is important to emphasize the pleiotropic effect of the 
absence of phospholipid turnover in the evolved and 
other strains. This absence is clearly advantageous under 
the PB11 PTS− scenario, where the strain is unable to 
use glucose efficiently, and a minimal increase in their 
ability to optimize carbon metabolism is manifested in 
its growth (PB11Δaas-lplT). In the evolved strains, this 
effect is not evident because both strains enhance glu-
cose uptake through the effects of the rppH and galR 
deletions and are not limited for growth on glucose as 
the PB11 strain [2]. However, the induction of phospho-
lipid degradation in these strains is apparently required 
for an increased growth rate, as shown by the inactiva-
tion of the fadD gene. The decrease in growth rate in the 
PB11Δaas-lplT-fadD strain also supports this proposal 
(Table 2).
Supported on the previous results, we propose the fol-
low strategy carried out by the PB11Δaas-lplT, PB12 and 
PB13 strains to overcome the absence of the aas-lplT 
operon. The activity of Lnt, but mainly of PldA and PldB 
are required to degrade PtdEtn and 2-acyl-GPE into fatty 
acids and glycerol-3-phosphoethanolamine. This latter 
compound is accumulated in the periplasmic space due 
to the lack of the LplT transporter (Fig.  7). In a second 
step, GDP would be responsible for G3P generation from 
the glycerophosphodiester molecule. With these reac-
tions, the periplasmic fatty acids and G3P concentrations 
increase while further transportation by the FadD and 
GlpT proteins, respectively, is carried out (Fig. 7).
Once inside the cell, G3P is available to be redirected 
towards the glycolytic pathway or to “novo” phospho-
lipid biosynthesis. On the other hand, the free fatty acids 
are also metabolized by the cell and are used to synthe-
size phospholipids or are degraded during β-oxidation 
(Fig.  7). This is possible in these strains because of the 
absence of catabolite repression due to the lack of the 
PTS system. Therefore, the evolved strains gain the 
capacity to recycle all the carbon molecules from phos-
pholipid degradation to de novo phospholipid biosyn-
thesis, glycolysis, and β-oxidation. These seem to favor 
the metabolism of evolved strains, allowing for a growth 
increase and, consequently, resulting in an increased 
fitness.
Table 3 RT‑qPCR mRNA expression values of  PtdEtn deg‑
radation, β‑oxidation and  phospholipid biosynthesis 
genes in the evolved strains
Relative mRNA concentrations of PB11, PB12 and PB13 strains, grown on glucose 
as the sole carbon source were determined by RT-qPCR. Data in this table are 
reported as relative expression levels of the parental strain JM101. The mRNA 
level of each gene in the parental strain was used as control to normalize the 
data, assigning it the value of one. Central carbon metabolism genes and other 
important genes have been previously reported and are listed in Additional 
file 4: Table S3
Genes PB11 PB12 PB13
2‑Acyl‑glycerophosphoethanolamine cycle
 aas 1.03 ± 0.05 0 0
 lnt 1.09 ± 0.26 1.47 ± 0.03 2.43 ± 0.46
 lplT 0.97 ± 0.08 0 0
 msbA 1.44 ± 0.08 2.25 ± 0.24 3.87 ± 0.71
PtdEtn degradation
 fadD 1.2 ± 0.26 0.66 ± 0.1 0.95 ± 0.26
 glpQ 1.44 ± 0.39 1.89 ± 0.35 1.90 ± 0.10
 glpT 2.59 ± 0.40 2.22 ± 0.05 63.46 ± 7.17
 lnt 1.09 ± 0.26 1.47 ± 0.03 2.43 ± 0.46
 pldA 1.71 ± 0.30 2.85 ± 0.08 4.79 ± 1.10
 pldB 0.74 ± 0.05 1.57 ± 0.28 1.65 ± 0.13
β‑oxidation
 fadA 30.50 ± 0.21 6.83 ± 1.07 7.52 ± 0.71
 fadB 33.13 ± 2.89 6.20 ± 1.03 4.12 ± 0.69
 fadD 1.2 ± 0.26 0.66 ± 0.1 0.95 ± 0.26
 fadE 9.12 ± 1.43 56.93 ± 1.75 13.68 ± 1.56
 fadL 2.14 ± 0.07 1.34 ± 0.02 2.12 ± 0.53
 fadR 2.66 ± 0.40 3.00 ± 0.16 4.48 ± 0.22
Fatty acid biosynthesis
 accA 1.08 ± 0.20 0.64 ± 0.04 0.62 ± 0.09
 accB 0.77 ± 0.05 0.78 ± 0.05 0.67 ± 0.10
 accD 0.64 ± 0.02 0.42 ± 0.04 0.23 ± 0.05
 fabA 2.25 ± 0.18 3.03 ± 0.16 4.21 ± 0.11
 fabB 1.99 ± 0.22 1.26 ± 0.12 2.63 ± 0.33
 fabD 1.25 ± 0.03 1.50 ± 0.05 1.95 ± 0.11
 fabF 0.66 ± 0.06 1.54 ± 0.05 2.88 ± 0.04
 fabG 0.69 ± 0.01 1.38 ± 0.11 1.74 ± 0.07
 fabH 1.02 ± 0.19 1.30 ± 0.24 2.05 ± 0.21
 fabI 2.04 ± 0.13 5.01 ± 0.20 3.00 ± 0.00
 fabR 0.90 ± 0.06 1.72 ± 0.11 2.12 ± 0.28
 fabZ 0.59 ± 0.07 1.84 ± 0.01 1.91 ± 0.24
Phospholipid biosynthesis
 plsB 2.30 ± 0.13 2.12 ± 0.50 2.52 ± 0.31
 plsC 0.52 ± 0.06 1.67 ± 0.12 2.35 ± 0.18
 plsX 2.39 ± 0.15 2.34 ± 0.28 2.55 ± 0.08
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Essential genetic features for the optimization 
in the aromatic biosynthesis pathway in the PB12 
strain
The ptsHIcrr deletion to increase the PEP availability is a 
widely employed strategy in metabolic engineering. The 
pleiotropic effect from that deletion has been analyzed 
from several approaches, in order to find a rational solution 
to overcome, essentially, the limited growth of the PTS− 
strains. The use of ALE as a tool in this field has allowed 
to solving this problem, however the appearance of unde-
sirable genetic changes that could bring another unpredict-
able detrimental effects is an important issue. The evolved 
strains generated here and its further analysis allowed 
identifying the main mutations responsibles for uptake and 
metabolism of glucose. Interestingly, despite both evolved 
strains shared this mutations (rppH, galR, and aas-lplT 
deletions), further rational genetic modifications to divert 
the carbon flux towards the aromatic biosynthesis pathway 
result in a differential aromatic yields [40, 41]. The remark-
able overproductive capacity of the PB12 over the PB13 
strain was the result of some metabolic properties derived 
from specific point mutations in both strains.
The overproductive capacity in the PB12 strain 
comes from a particular uptake rate capacity 
(5.5 mmol glc h−1 gDW) and glucose catabolism that pre-
vent an overflow through the glycolytic pathway, which in 
turn reduces the waste carbon in the acetic acid form [8]. 
In addition, the strategies to redirect the carbon flow to 
the aromatic biosynthesis pathway through the overex-
pression of key genes diminish even more the acetic acid 
production [9, 10]. In the other hand, as result of the high 
levels of galP transcripts, the PB13 shows an increased 
uptake rate (8.5  mmol  glc  h−1  gDW) that generates the 
overflow responsible of the acetic acid production in simi-
lar concentrations compared to the wild type strain (56 % 
molar percentage) [8]. This particularity in the PB13 strain 
represent a disadvantage for the aromatic compounds 
production, however, the genetic changes associated to 
the higher galP gene transcription is unknown.
Interestingly, some efforts in our laboratory to reproduce 
this metabolic behavior by reverse metabolic engineering 
approaches in other E. coli strains result in low aromatic 
compounds yields (data not shown), which indicate the 
importance of the genetic architecture. It seems the intrin-
sic genetic characteristics of the JM101 strain is desirable 
for this purpose, however the same fact imply that some 
other genetic backgrounds could be a better option for 
optimize the production of aromatic compounds.
Conclusions
The deletion of a chromosomal fragment containing 
important genes, such as rppH, mutH, galR and the aas-
lplT operon, is proposed to be one of the early and most 
important adaptive events during the reported ALE pro-
cess [2]. The increase of mRNA levels of glycolytic genes 
because of the RppH pyrophosphohydrolase activity defi-
ciency and the increased glucose uptake through GalP 
due to the lack of GalR [2, 6–8], in the PB12 and PB13 
PTS− evolved strains allows to enhance their glycolytic 
metabolism. However, despite this growth advantage, 
the cells also lost their primary membrane phospholipid 
turnover pathway coded by the aas-lplT operon. The 
evolved strains also share two additional point mutations 
in the glpT and dhaM genes.
As the inactivations in the glpT and fadD genes sug-
gests, the lack of the PtdEtn turnover metabolism capacity 
in the evolved strains was replaced with the utilization of 
the degradation pathway where phospholipids are trans-
formed to their basic components: G3P and free fatty acids. 
The increase of more than 50 % in the μ of the derivative 
PB11Δaas-lplT strain supports the adaptive nature of this 
metabolic pathway blockage. In this situation, the evolved 
strains additionally improved carbon metabolism by forc-
ing the cell to synthesize fatty acids de novo and taking 
advantage of the energy generated by β-oxidation and 
glycolysis during the degradation of fatty acids and G3P, 
respectively. Ultimately, the balance between de novo syn-
thesis, β-oxidation, and glycolysis seems to be favorable in 
both PTS− PB12 and PB13 evolved strains, allowing for an 
increase in their growth rates on glucose as the only car-
bon source. These results indicate an important metabolic 
plasticity of these strains that lack PTS to utilize additional 
mutations (in glpT and dhaM genes) that occurred in the 
ALE to transform the deletion disadvantage of the aas-lplT 
operon lost in an advantage for growing faster on glucose 
by utilizing the capacity of recycling phospholipids as addi-
tional carbon and energy resources (Fig. 7). The RT-qPCR 
values of the genes involved in the capacity of recycling 
phospholipids that in general are overexpressed in the PB12 
and PB13 evolved strains, are in agreement with this pro-
posed recycling capacity that is enhanced and functional in 
the evolved strains and mainly in PB13 (Table 3).
The high increase in the growth rate observed with 
the deletion of rppH, aas, lplT and the entire chromo-
somal region in PB11 derivatives indicates that the con-
tribution to the growth recovery by point mutations is 
minimal compared to the benefits provided by the chro-
mosomal fragment deletion. However, there is a growth 
rate difference between both evolved strains caused by 
the higher galP gene expression in the PB13 strain (38-
fold increase). It is possible that one of the point muta-
tions present in the PB13 strain could have an indirect 
role in the increased galP transcription observed in this 
strain. In future experiments, we will individually inacti-
vate these genes to see their effect on galP expression and 
growth rate.
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The enormous stress caused by the elimination of PTS 
triggered a chromosomal rearrangement where the DNA 
mismatch repair system was affected due to the lack of 
mutH in the deleted DNA fragment. Consequently, the 
mutation rate increased. The appearance of a mutator 
population in bacterial cultures is a frequent event dur-
ing limited growth conditions to improve its chances of 
survival by generating variation. In these PTS− evolved 
strains, this genetic novelty displaces alternative sub-
populations because it creates in the resulting variants 
an improved capacity to metabolize glucose due to the 
absence of the rppH, aas, lplT and galR genes, ultimately 
increasing the fitness of the evolved strains. Interestingly, 
the absence of this specific chromosomal fragment could 
have given the cell the capacity to generate variation to 
explore several adaptive solutions that could overcome 
the lack of PTS.
Several ALE experiments have demonstrated the effi-
ciency and how fast the evolution works in E. coli [2, 
5, 42, 43]. This intrinsic feature has been exploited in 
biotechnology, resulting in a common practice during 
metabolic engineering strategies to improve particular 
features in the cell for enhance several bioprocess. In 
the PB12 and PB13, it was demonstrated that a particu-
lar qsGlc derived from specific genetic changes is the 
decisive factor to determine the efficiency in the aro-
matic compounds yields. Additionally, some results of 
preliminary reverse-metabolic engineering approaches 
to increase the glucose uptake in overproductive aro-
matic compounds PTS− strains, shows that the genetic 
architecture of the cell is essential. This issue it should be 
taking into account in order to enhance the productive 
capacities of the different metabolites in the industry.
The appearance of a mutator genotype in this kind of 
metabolic engineering strategies (ALE), allows the cell 
population to explore different genetic solutions. How-
ever, this genetic change in conjunction with the other 
deleted genes (galR, rppH, aas and lplT) resulted in the 
solution for an increased growth rate. At the moment 
after the deletion occurred, the cell culture could explore 
ways to diminish its mutation rate to decrease the proba-
bility of gaining deleterious mutations [44, 45], a fact that 
was not detected in both isolated evolved strains. Rather 
than decreasing, the PB13 strain increased its mutation 
rate. Among the genetic changes that could be involved 
in this increase is the polA mutation, which has a role in 
processing Okazaki DNA fragments and in filling gaps 
during the excision-repair processes. It is possible that 
this mutation could affect the performance of the DNA 
repair process. In the PB12 strain, where the mutation 
rate is moderate, the chance of generating deleterious 
mutations is still present. For that reason, it is desirable 
for stability and production purposes to consider the 
return of the wild type mutH gene, particularly in those 
PB12 derivative strains that are used for aromatic com-
pound production. Nevertheless, cells where deleterious 
mutation could have occurred were not detected because 
of their inability to reproduce. In fact, increasing muta-
tion rates in strains lacking mutH allows the cells in 
this culture to more quickly test several genetic changes 
(120 h in the reported study) and their effect on survival 
in different derivative cells.
In fact, an alternative for metabolite production pur-
poses is that the presence of a mutator gene could allow 
mutations that enhance the production of the specific 
product. We cannot rule out this possibility in some of 
the PB12 derivatives that have increased capacities for 
producing aromatic compounds. For this reason, the 
genome of some of these strains will be resequenced.
Materials and methods
Bacterial strains, growth conditions, and recombinant DNA 
techniques
E. coli strains JM101 [F’ traD36 proAB+ lacIq 
lacZΔM15/supE thi Δ(lac-proAB) rpoS(33am)], PB11 
[JM101Δ(ptsH, ptsI, crr):: kan], PB12 (PB11ev1, PTS− 
Glc+) and PB13 (PB11ev2, PTS− Glc+) derivatives have 
previously been described [2, 6–8]. The derivatives of 
these strains utilized in this report (rppH, aas, lplT, glpT, 
dhaM, glpQ and fadD genes were knockout inactivated) 
were obtained by the Datsenko and Wanner method [46] 
using the oligonucleotides listed in Table S4 that is availa-
ble in the Additional file 3: Figure S1. All gene disruptions 
were confirmed by PCR (data not shown). For inocula 
preparations, strains stored at −72  °C in glycerol were 
inoculated into Luria broth (LB) for overnight growth.
The cultures of the PB12 and PB13 strains that were uti-
lized for DNA preparation for genome sequencing were 
obtained from the original culture that was kept frozen in 
glycerol [2, 7]. For μ determinations, cells were grown in 
LB and inoculated into M9 minimal medium with 2 g/L of 
glucose as the only carbon source. When the cultures were 
growing exponentially, they were inoculated into the same 
prewarmed (50 mL) medium, using 250 mL baffled flasks at 
37 °C and stirred at 300 rpm with a starting optical density 
at 600  nm (O.D.600nm) =  0.1. O.D.600nm values were meas-
ured using a Klett/Summerson photocolorimeter, model 
800-3. All specific μ values presented in Table 2 and Fig. 5a 
are the averages of at least three independent cultures, each 
one in duplicate. For RNA isolation and RT-qPCR analyses, 
duplicate cultures were grown in 1 L fermentors using M9 
medium with 2  g/L of glucose as the sole carbon source. 
Cultures were grown at 37 °C, stirred at 600 rpm, and with 
an air flow rate of 1 vvm with a starting O.D.600nm = 0.1. For 
RT-qPCR determinations, cells from the different fermen-
tations were collected in the log phase at O.D.600nm = 1 [6].
Page 16 of 18Aguilar et al. Microb Cell Fact  (2015) 14:194 
DNA extraction from parental and evolved PB13 strains 
for genomic analysis
Two overnight cultures of the E. coli strains JM101, PB11, 
and PB13 were grown from their frozen original stocks in 
liquid LB medium. DNA was extracted with a maxiprep 
phenol extraction and ethanol precipitation method [2, 
6, 47] and purified with the Pure Link PCR purification 
kit (Invitrogen, USA). Quality and quantity of extracted 
DNA was verified as recommended by Roche Nimble-
Gen (RN) and by UNAM Massive DNA Sequencing 
Unit. All strains were sequenced with Illumina Inc. Gallx 
high throughput technology. The JM101, PB11 and PB13 
strains were resequenced with Ion Torrent PGM technol-
ogy. The nucleotide sequence of the PB12 strain has been 
previously reported [2].
Library constructions and sequencing
DNA samples from the JM101, PB11 and PB13 strains 
were submitted to the Massive DNA Sequencing Unit 
of UNAM for its paired-ended (PE) library construc-
tion and genome sequencing. PE library was constructed 
following Illumina Inc. recommendations, which were 
previously described for the nucleotide sequence deter-
mination of strain PB12 [2]. The Ion Xpress™ Plus 
Fragment Library Kit was used for the library construc-
tion, and genome sequencing by Ion Torrent PGM 
was performed following recommendations from Life 
Technologies.
Genome de novo assembly and variant identification
The protocol used for the “de novo” assembly and variant 
identification from the data obtained by high throughput 
sequencing with the Illumina GAIIx method was previ-
ously described [2]. Ion Torrent reads were trimmed 
based on their quality using the FASTX-Toolkit (Hannon 
Lab. FASTX-Toolkit.). These reads were mapped against 
the JM101 assembly using bwa 0.6.2 [51]. Variants were 
called using Samtools 0.1.18 [48] and compared with var-
iant calls from the PB13 assembly. Only variants reported 
by both methods (de novo assembly and Ion Torrent 
read mapping) were reported. For most of the analyses, 
the Instituto de Biotecnología, UNAM cluster resources 
were used.
DNA sequencing of putative mutations by Sanger 
methodology
DNA regions containing putative mutations detected 
in the PB12 strain were previously reported [2]. For the 
PB13 strain, the point mutations detected by variant 
identification were confirmed. PCR amplifications were 
performed using the oligonucleotide primers listed in 
Additional file  5: Table S4 (shown in Additional file  3: 
Figure S1), purified by the Pure Link PCR purification 
kit, and sequenced by the Sanger methodology with 
the Taq FS Dye Terminator Cycle Sequencing Fluores-
cence-Based Sequencing in a Perkin Elmer/Applied 
Biosystems Model 3730. Sequence differences in 14 of 
the mutations are shown in PB13 in Table 1a and were 
confirmed by examination of the trace data (data not 
shown).
Estimation of the mutation rate in the different E. coli 
strains
Determination of mutation rates was based on mutation 
at a single locus, rpsL (rifampicin-resistant mutants). 
Mutation rates were determined by a modified Luria-
Delbrück fluctuation test [30, 31]. Briefly, 100  µL of 
30 overnight cultures were independently mixed and 
plated in LB agar plates containing the antibiotic selector 
(200 µg/mL of streptomycin). Samples of 100 µL from a 
10−6 dilution from five overnight cultures were used to 
estimate the total viable count in drug-free LB plates. The 
MSS-LME and the LC methods [32] were used to esti-
mate the number of mutants.
RNA extraction, cDNA synthesis, and RT‑qPCR analysis
As previously described, total RNA was isolated and 
purified using a modified hot phenol method reported 
elsewhere [2, 6, 7], and a RevertAid™ H minus First 
Strand cDNA Synthesis kit was used to synthesize 
cDNA according to the manufacturer’s instructions 
(Fermentas, Burlington, Canada). For each reaction, 
approximately 5 μg of RNA and a mixture of 10 pmol/
mL of specific DNA reverse primers (b) for each meas-
ured gene were used. The nucleotide sequences of these 
genes in PB12 have been previously published [2, 6, 7] 
RT-qPCR was performed with the ABI Prism 7300 Real-
Time PCR System (Perkin Elmer/Applied Biosystems, 
Foster City, CA) using the MaximaR SYBR Green/ROX 
qPCR Master Mix (2x) kit (Fermentas LifeSciences), and 
reaction conditions were previously described [2]. For 
each gene, all experiments were performed in triplicate 
from two different fermentations to obtain very similar 
values (differences <0.3 SD). A non-template control 
reaction mixture was included for each gene. Standard 
curves were constructed to evaluate PCR efficiency, and 
all the qPCR assays showed a high efficiency of ampli-
fication (90–100  %) because the genes had R2 values 
above 0.9976 with slopes between −3.4 and −3.7. All 
RT-qPCR experiments were compliant with the MIQE 
(Minimum Information for Publication of Quantitative 
Real-Time PCR Experiments) guidelines [49]. The quan-
tification technique used to analyze the data was the 
2−ΔΔCq method described by Livak and Schmittgen [50]. 
Data were normalized using the ihfB gene as an internal 
control.
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In vivo labeling of E. coli with [14C]acetate and analysis 
of lipid extracts
The lipid composition of the different E. coli strains was deter-
mined by triplicate following labeling with [1-14C]acetate (Per-
kin Elmer). LB cultures (1.5 mL) were inoculated to an initial 
optical density at 600  nm (OD600) of 0.1 from precultures 
grown in the same medium. After the addition of 1 μCi/mL 
[1-14C]acetate to each culture, they were incubated for 24, 48 
or 72 h. The cells were harvested by centrifugation and resus-
pended in 100 μL of water. The lipids were extracted according 
to the method of Bligh and Dyer [51]. The chloroform phase 
was used for lipid analysis by one-dimensional thin-layer chro-
matography (TLC) using high-performance TLC silica gel 60 
plates (Merck) and ethyl acetate-hexane-acetic acid (60:40:5 
[vol/vol/vol]) as the mobile phase. Two-dimensional TLC was 
performed as described previously [52]. Radioactivity was 
detected using a Storm 820 PhosphorImager (Amersham Bio-
sciences). Image analysis and signal quantification were car-
ried out using ImageQuant TL (Amersham Biosciences).
Additional files
Additional file 1: Table S1. This table lists the data provided by Winter 
Genomics Inc. (WG) obtained from the whole genome sequence of the 
PB13 strain in comparison to the parental strains JM101 and PB11. Section 
A includes a list of 13 genes in which, accordingly to this company non‑
synonymous point mutations occurred changing the coding regions in 
structural genes. The table also includes (Section B) the list of 8 genes in 
which synonymous mutations also occurred.
Additional file 2: Table S2. Mutation rates in both evolved strains 
based on mutation appearance in the rpoB locus. Mutation rates were 
determined by a modified Luria‑Delbrück fluctuation test, employing the 
MSS‑MLE and the LC methods in the estimation of the number of mutants 
[30–32]. The mutation frequency also was determinated.
Additional file 3: Figure S1. RT‑qPCR values of central metabolism and 
regulatory genes. Relative mRNA concentrations of central metabolism 
and regulatory genes of PB12 and PB13 strains, grown in glucose as the 
sole carbon source were determined by RT‑qPCR. The PB12 values have 
been previously reported [2, 6, 7] and are presented here for discussion 
and comparison purposes. Data in this Figure are reported as relative 
expression levels of the parental strain JM101. The mRNA level of each 
gene in the parental strain was used as control to normalize the data, 
assigning it the value of one (see Materials and Methods).
Additional file 4: Table S3. RT‑qPCR mRNA expression values of central 
carbon metabolism, in the evolved strains. Relative mRNA concentrations 
of central metabolism and regulatory genes of PB11, PB12 and PB13 strains, 
grown in glucose as the sole carbon source were determined by RT‑qPCR. 
Most of these values have been previously reported (*) and are presented 
here for discussion and comparison purposes [2, 9–11]. Data in this table 
are reported as relative expression levels of the parental strain JM101. The 
mRNA level of each gene in the parental strain was used as control to 
normalize the data, assigning it the value of one. N.D. Not determined.
Additional file 5: Table S4. Oligonucleotides employed in this study. 
This table lists the oligonucleotides utilized in this work. Section A shows 
the oligonucleotides used for DNA sequencing with the Sanger method, 
for the gene disruption confirmations generated by Datsenko‑Wanner 
method and the deletion confirmation that occurred in the evolved 
strains. Section B lists the oligonucleotides utilized for gene disruption 
with the Datsenko‑Wanner methodology. Section C lists the oligonucleo‑
tides utilized for RT‑qPCR analysis not previously reported.
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